All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| RYTM / Rhythm Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| RXRX / Recursion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
| ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| RANI / Rani Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
| MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| TRDA / Entrada Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MRUS / Merus N.V.
|
|
|
|
|
|
|
|
| ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
| TRML / Tourmaline Bio, Inc.
|
|
|
|
|
|
|
|
| HRMY / Harmony Biosciences Holdings, Inc.
|
|
|
|
|
|
|
|
| CLYM / Climb Bio, Inc.
|
|
|
|
|
|
|
|
| DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| INCY / Incyte Corporation
|
|
|
|
|
|
|
|
| KYMR / Kymera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MIRM / Mirum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SLNO / Soleno Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BSLK / Bolt Projects Holdings, Inc.
|
|
|
|
|
|
|
|
| GERN / Geron Corporation
|
|
|
|
|
|
|
|
| KALV / KalVista Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| LAB / Standard BioTools Inc.
|
|
|
|
|
|
|
|
| BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| REPL / Replimune Group, Inc.
|
|
|
|
|
|
|
|
| OCS / Oculis Holding AG
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| RBRK / Rubrik, Inc.
|
|
|
|
|
|
|
|
| RVMD / Revolution Medicines, Inc.
|
|
|
|
|
|
|
|
| EXEL / Exelixis, Inc.
|
|
|
|
|
|
|
|
| ALXO / ALX Oncology Holdings Inc.
|
|
|
|
|
|
|
|
| XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BOLT / Bolt Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
